Chlorotoxin-functionalized mesoporous silica nanoparticles for pH-responsive paclitaxel delivery to Glioblastoma multiforme
2024

Chlorotoxin-Functionalized Nanoparticles for Targeted Drug Delivery in Brain Cancer

publication Evidence: moderate

Author Information

Author(s): Mundžić Mirjana, Ultimo Amelia, Mladenović Minja, Pavlović Aleksandra, Gobbo Oliviero L., Ruiz-Hernandez Eduardo, Santos-Martinez Maria Jose, Knežević Nikola Ž.

Primary Institution: BioSense Institute, University of Novi Sad

Hypothesis

Can mesoporous silica nanoparticles be used for pH-responsive delivery of paclitaxel to glioblastoma cells?

Conclusion

The study successfully developed pH-responsive nanoparticles that enhance the delivery and cytotoxicity of paclitaxel to glioblastoma cells.

Supporting Evidence

  • Paclitaxel-loaded nanoparticles showed higher cytotoxicity when functionalized with chlorotoxin.
  • The release of paclitaxel was significantly higher in acidic conditions compared to neutral pH.
  • Nanoparticles demonstrated effective internalization by glioblastoma cells in vitro.

Takeaway

Scientists created tiny particles that can deliver medicine directly to brain cancer cells when the environment is slightly acidic, making the treatment more effective.

Methodology

The study involved synthesizing mesoporous silica nanoparticles, loading them with paclitaxel, and testing their drug release and cytotoxicity in U87 glioblastoma cells.

Limitations

The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.heliyon.2024.e41151

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication